APA (7th ed.) Citation

DA, Y., ER, A., BR, D., J, E., A, B., DR, D., . . . 3rd, B. H. (2017). TITAN: Phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer. Breast cancer research and treatment, 164(3), 649. https://doi.org/10.1007/s10549-017-4285-6

Chicago Style (17th ed.) Citation

DA, Yardley, et al. "TITAN: Phase III Study of Doxorubicin/cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-stage Triple-negative Breast Cancer." Breast Cancer Research and Treatment 164, no. 3 (2017): 649. https://doi.org/10.1007/s10549-017-4285-6.

MLA (9th ed.) Citation

DA, Yardley, et al. "TITAN: Phase III Study of Doxorubicin/cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-stage Triple-negative Breast Cancer." Breast Cancer Research and Treatment, vol. 164, no. 3, 2017, p. 649, https://doi.org/10.1007/s10549-017-4285-6.